Home » Clinical Trials » Search Clinical Trials

Therapeutic Areas: Neurology | Oncology

Brain Metastases Clinical Trials

A listing of Brain Metastases medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Arizona

Phoenix Arizona 85013

Patients are needed to participate in a clinical research study of ceritinib 750mg to evaluate Glioblastoma or Brain Metastases

California

Beverly Hills California 90211

A Phase 2 clinical study for patients with Non-Small Cell Lung Cancer, Leptomeningeal Metastases or Brain Metastases

Duarte California 91010

A clinical trial to evaluate treatments using Abemaciclib for patients with Breast Cancer or Brain Metastases

La Jolla California 92037-0845

A clinical trial to evaluate treatments using Abemaciclib for patients with Breast Cancer or Brain Metastases

La Jolla California 92093

A Phase 2 clinical study for patients with Non-Small Cell Lung Cancer, Leptomeningeal Metastases or Brain Metastases

Los Angeles California 90033

A Phase 2 clinical study for patients with Non-Small Cell Lung Cancer, Leptomeningeal Metastases or Brain Metastases

View More ▼

Newport Beach California 92663

A Phase 2 clinical study for patients with Non-Small Cell Lung Cancer, Leptomeningeal Metastases or Brain Metastases

San Francisco California 94115

A clinical trial to evaluate treatments using Abemaciclib for patients with Breast Cancer or Brain Metastases

San Francisco California 94115

A Phase 2 clinical study for patients with Non-Small Cell Lung Cancer, Leptomeningeal Metastases or Brain Metastases

Santa Monica California 90404

A clinical trial to evaluate treatments using Abemaciclib for patients with Breast Cancer or Brain Metastases

Santa Monica California 90404

A clinical trial to evaluate treatments using Afatinib for patients with Brain Cancer

Santa Monica California 90404

A Phase 1 clinical study for patients with Brain Metastases

Santa Monica California 90404

A Phase 2 clinical study for patients with Non-Small Cell Lung Cancer, Leptomeningeal Metastases or Brain Metastases

Colorado

Aurora Colorado 80045

A clinical trial to evaluate treatments using Abemaciclib for patients with Breast Cancer or Brain Metastases

Aurora Colorado 80045

A Phase 2 clinical study for patients with Non-Small Cell Lung Cancer, Leptomeningeal Metastases or Brain Metastases

Connecticut

Fairfield Connecticut 06824

Patients are needed to participate in a clinical research study of NovoTTF-100M device and Best Standard of Care to evaluate Brain Metastases From Non-small Cell Lung Cancer (NSCLC)

New Haven Connecticut 06520-8020

A clinical trial to evaluate treatments using Abemaciclib for patients with Breast Cancer or Brain Metastases

District of Columbia

Washington District of Columbia 20007

A clinical trial to evaluate treatments using Abemaciclib for patients with Breast Cancer or Brain Metastases

Washington District of Columbia 20007

A Phase 2 clinical study for patients with Non-Small Cell Lung Cancer, Leptomeningeal Metastases or Brain Metastases

Florida

Fort Myers Florida 33916-2233

A clinical trial to evaluate treatments using Abemaciclib for patients with Breast Cancer or Brain Metastases

Tampa Florida 33612-9497

A clinical trial to evaluate treatments using Abemaciclib for patients with Breast Cancer or Brain Metastases

Georgia

Atlanta Georgia 30322

A clinical trial to evaluate treatments using Abemaciclib for patients with Breast Cancer or Brain Metastases

Atlanta Georgia 30309

Patients are needed to participate in a clinical research study of NovoTTF-100M device and Best Standard of Care to evaluate Brain Metastases From Non-small Cell Lung Cancer (NSCLC)

Hawaii

Honolulu Hawaii 96819

A clinical trial to evaluate treatments using Abemaciclib for patients with Breast Cancer or Brain Metastases

Illinois

Warrenville Illinois 60555

Patients are needed to participate in a clinical research study of NovoTTF-100M device and Best Standard of Care to evaluate Brain Metastases From Non-small Cell Lung Cancer (NSCLC)

Kentucky

Louisville Kentucky 40202

A clinical trial to evaluate treatments using Abemaciclib for patients with Breast Cancer or Brain Metastases

Louisville Kentucky 40202

Patients are needed to participate in a clinical research study of NovoTTF-100M device and Best Standard of Care to evaluate Brain Metastases From Non-small Cell Lung Cancer (NSCLC)

Massachusetts

Boston Massachusetts 02115

A clinical research study of Alectinib and Bevacizumab for the treatment of Non-Small Cell Lung Cancer (NSCLC)

Boston Massachusetts 02155

A clinical research study of Alectinib and Bevacizumab for the treatment of Non-Small Cell Lung Cancer (NSCLC)

Boston Massachusetts 02215

A clinical trial to evaluate treatments using Abemaciclib for patients with Breast Cancer or Brain Metastases

Boston Massachusetts 02115

A Phase 2 clinical study for patients with Brain Metastases or Solid Tumors

Boston Massachusetts 02115

A Phase 2 clinical study for patients with Brain Metastases or Solid Tumors

View More ▼

Boston Massachusetts 02115

A Phase 2 clinical study for patients with Radionecrosis or Brain Metastases

Boston Massachusetts 02111

Patients are needed to participate in a clinical research study of NovoTTF-100M device and Best Standard of Care to evaluate Brain Metastases From Non-small Cell Lung Cancer (NSCLC)

Michigan

Ann Arbor Michigan 48109

A clinical trial to evaluate treatments using Abemaciclib for patients with Breast Cancer or Brain Metastases

Ann Arbor Michigan 48109

A Phase 1 clinical study for patients with Brain Metastases

Jackson Michigan 49201

A Phase 1 clinical study for patients with Brain Metastases

Missouri

St. Louis Missouri 63110

A clinical trial to evaluate treatments using Abemaciclib for patients with Breast Cancer or Brain Metastases

St. Louis Missouri 63110

A Phase 1 clinical study for patients with Brain Metastases

New Jersey

Basking Ridge New Jersey

Patients are needed to participate in a clinical research study evaluating Whole Brain Radiotherapy (WBRT) and Sorafenib for the treatment of Breast Cancer or Brain Metastases

New Brunswick New Jersey 08903

A Phase 1 clinical study for patients with Brain Metastases

New Mexico

Albuquerque New Mexico 87102

A clinical trial to evaluate treatments using Abemaciclib for patients with Breast Cancer or Brain Metastases

New York

Commack New York 11725

Patients are needed to participate in a clinical research study evaluating Whole Brain Radiotherapy (WBRT) and Sorafenib for the treatment of Breast Cancer or Brain Metastases

New York New York 10016

A clinical trial to evaluate treatments using Abemaciclib for patients with Breast Cancer or Brain Metastases

New York New York 10065

A clinical trial to evaluate treatments using Abemaciclib for patients with Breast Cancer or Brain Metastases

New York New York 10065

A Phase 2 clinical study for patients with Brain Metastases or Solid Tumors

New York New York 10065

Patients are needed to participate in a clinical research study evaluating Whole Brain Radiotherapy (WBRT) and Sorafenib for the treatment of Breast Cancer or Brain Metastases

View More ▼

New York New York 10021

Patients are needed to participate in a clinical research study of NovoTTF-100M device and Best Standard of Care to evaluate Brain Metastases From Non-small Cell Lung Cancer (NSCLC)

Rockville Centre New York

Patients are needed to participate in a clinical research study evaluating Whole Brain Radiotherapy (WBRT) and Sorafenib for the treatment of Breast Cancer or Brain Metastases

Sleepy Hollow New York

Patients are needed to participate in a clinical research study evaluating Whole Brain Radiotherapy (WBRT) and Sorafenib for the treatment of Breast Cancer or Brain Metastases